Contact
Please use this form to send email to PR contact of this press release:
invIOs presents positive patient data from ongoing Phase 1b trial of APN401 cell therapy in advanced solid tumors at SITC 2022
TO:
Please use this form to send email to PR contact of this press release:
invIOs presents positive patient data from ongoing Phase 1b trial of APN401 cell therapy in advanced solid tumors at SITC 2022
TO: